Maha Health Minster asks Centre to formulate COVID-19 vaccine allotment criteria
He alleged that many states which are smaller than Maharashtra in terms of population and the number of patients, have received…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biotech start-up Vaccitech files for US IPO
Vaccitech owns the technology behind the COVID-19 vaccine developed by Oxford University and AstraZeneca
Iran in discussions with India for second shipment of COVID-19 vaccines
India has scaled down the export of coronavirus vaccines following a surge in the demand for those within the country in view of a…
Urgent need for disease-modifying drugs to arrest Parkinson’s disease progression: GlobalData
If any disease-modifying therapy managed to enter the PD market, it would revolutionise the treatment paradigm and generate a…
SII is legally bound to supply COVID-19 vaccines: COVAX
The pact specified Gavi would receive from SII 1.1 billion doses of either the AstraZeneca vaccine or that of Novavax, with 200…
J&J in discussions with Indian regulator to begin trial of single-dose vaccine
India has indicated that any vaccine maker must conduct such a trial for a shot to be considered for its immunisation programme
SII repays South Africa for COVID-19 vaccines that were not delivered
A million doses that had already been delivered, have been sold on to other countries in the African Union
Remdesivir’s price must not be more than Rs 1400 per vial: Maha Health Minister
Tope said with a rapid rise in COVID-19 cases, the state may need 1.5 lakh Remdesivir injections daily which would require ramping…
India to assess side effects of COVID-19 vaccine
India is currently administering AstraZeneca's COVID-19 vaccine and a shot developed at home by Bharat Biotech
OTC Drugs and E-Pharmacies: High time for regulation?
Renuka Abraham, Senior Associate and Priya Venkatesan, Associate with Spice Route Legal’s corporate practice group explain that…